Forte Biosciences, Inc. (FBRX)
FBRX moved a median of 0.00% 30 minutes after news, and -1.12% by the close. How FBRX actually reacts to news — the realized, point-in-time move the market made, measured across 203 labeled events over the last three years with zero look-ahead.
FBRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 167 |
| 30-min | 0.00% | 43% | 184 |
| 60-min | 0.00% | 48% | 185 |
| to close | -1.12% | 42% | 193 |
| Middle 50% of FBRX reactions | -2.38% to +1.67% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 203 |
Half of all Forte Biosciences, Inc. news events land between -2.38% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How FBRX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 11 | +0.01% | 64% | +0.12% |
| Coverage initiations | 16 | +1.35% | 56% | +0.93% |
| Rating reiterations | 16 | 0.00% | 31% | +5.28% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how FBRX ranks against every other measured name →
That’s how FBRX usually reacts — get an email when it moves on news →Email me when FBRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to FBRX's baseline. Nothing else.
Recent FBRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | -0.04% | -0.12% | |
| FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | -0.04% | — | |
| Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.01% | +0.05% | |
| Are FBRX, LXFR, HUN, OLN Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.04% | +0.01% | |
| Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | -0.01% | -0.10% | |
| argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline | Press release | Business Wire | +0.07% | +0.12% | |
| FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.07% | +0.12% | |
| FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period | Press release | Business Wire | +18.45% | +72.71% | |
| Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update | Press release | Business Wire | +1.60% | +11.16% | |
| Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules | Press release | Business Wire | +1.44% | -8.06% | |
| Forte Biosciences Announces Pricing of $150 Million Public Offering | Press release | Business Wire | +7.28% | +16.34% | |
| Forte Biosciences Announces Proposed Public Offering | Press release | Business Wire | +7.28% | +16.34% | |
| Forte Biosciences, Inc. Announces 2025 Results and Provides Update | Press release | Business Wire | +1.40% | -8.54% | |
| Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules | Press release | Business Wire | +0.96% | -4.83% | |
| Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules | Press release | Business Wire | +1.39% | -4.12% | |
| Forte Biosciences, Inc. to Present at Upcoming Investor Meetings | Press release | Business Wire | +1.85% | -0.84% | |
| Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules | Press release | Business Wire | -0.78% | -9.15% | |
| Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules | Press release | Business Wire | +0.18% | +2.56% | |
| Form 10-Q Forte Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.44% | +4.14% | |
| Form 8-K Forte Biosciences, Inc. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +1.44% | +4.14% | |
| Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update | Press release | Business Wire | +1.44% | +4.14% | |
| Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences | Press release | Business Wire | +0.00% | -5.05% | |
| Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules | Press release | Business Wire | +0.00% | -5.63% | |
| Form S-8 Forte Biosciences, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -0.95% | |
| Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium | Press release | Business Wire | — | +10.49% | |
| Form 10-Q Forte Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +5.28% | |
| Form 8-K Forte Biosciences, Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.28% | |
| Forte Biosciences, Inc. Announces Results and Provides Update | Press release | Business Wire | +0.00% | +5.28% | |
| Form 8-K Forte Biosciences, Inc. For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +1.84% | +4.49% | |
| Forte Biosciences Announces Pricing of $75 Million Public Offering | Press release | Business Wire | +2.32% | -3.73% | |
| Forte Biosciences Announces Proposed Public Offering | Press release | Business Wire | +2.32% | -3.73% | |
| Form 8-K Forte Biosciences, Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | -1.70% | -31.03% | |
| Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study | Press release | Business Wire | -1.70% | -31.03% | |
| Form 8-K Forte Biosciences, Inc. For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +4.22% | +2.41% | |
| Form 10-Q Forte Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.12% | -2.97% | |
| Form 8-K Forte Biosciences, Inc. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.12% | -2.97% | |
| Forte Biosciences, Inc. Announces Results and Provides Update | Press release | Business Wire | +0.12% | -2.97% | |
| Form ARS Forte Biosciences, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | -1.47% | |
| Form DEF 14A Forte Biosciences, Inc. For: May 29 | SEC filing · Form DEF | SEC EDGAR | — | -1.47% | |
| Form 8-K Forte Biosciences, Inc. For: Apr 18 | SEC filing · Form 8-K | SEC EDGAR | -2.41% | -8.01% | |
| Form 8-K Forte Biosciences, Inc. For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -9.18% | |
| Form EFFECT Forte Biosciences, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -8.13% | |
| Forte Biosciences, Inc. Announces Results and Provides Clinical Update | Press release | Business Wire | -5.09% | -14.16% | |
| Form 10-K Forte Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -5.09% | -14.16% | |
| Form S-3 Forte Biosciences, Inc. | SEC filing · Form S-3 | SEC EDGAR | -5.09% | -14.16% | |
| Form S-8 Forte Biosciences, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -7.12% | |
| Forte Biosciences, Inc. to Present at Upcoming Investor Meetings | Press release | Business Wire | +0.82% | -5.67% | |
| Form 8-K Forte Biosciences, Inc. For: Jan 24 | SEC filing · Form 8-K | SEC EDGAR | -3.19% | -4.75% | |
| Form DEF 14A Forte Biosciences, Inc. For: Jan 24 | SEC filing · Form DEF | SEC EDGAR | -5.13% | +7.08% | |
| Form EFFECT Forte Biosciences, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -4.62% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the FBRX section they belong to.
Where else FBRX is measured.
FBRX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Forte Biosciences, Inc.'s median reaction calculated?
Every labeled FBRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 203 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of FBRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does FBRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.